Inhalation
News/ News/ R&D/ Top stories
Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19
Phil Taylor
antiviral, coronavirus, COVID-19, Gilead Sciences, infectious disease, Inhalation, remdesivir
0 Comment
Partner content/ Partner Content/ Press releases
FREE TO ATTEND | Inhalation & Respiratory Drug Delivery Event: Virtual
e.hawkings@oxfordglobal.co.uk
drug delivery, formulation, Inhalation, medical devices, respiratory
0 Comment
08 – 09 July 2020 | BST (UTC+1) | FREE TO ATTEND
Partner Content/ Partner content/ Press releases
FREE TO ATTEND | Formulation & Drug Delivery Event: Virtual
e.hawkings@oxfordglobal.co.uk
drug delivery, formulation, Inhalation, medical devices, respiratory
0 Comment
FREE TO ATTEND
Partner Content/ Partner content/ Press releases
Formulation & Drug Delivery Series US
e.hawkings@oxfordglobal.co.uk
drug delivery, formulation, healthcare, Inhalation, medical devices
0 Comment
Join 250+ pharmaceutical leaders, experts & researchers
Partner content/ Partner Content/ Press releases
Key Opinion Leaders to present at the Respiratory Drug Delivery Conference
Jinna Sidhu
drug delivery, Inhalation, lung cancer, pharma, respiratory
0 Comment
Respiratory Drug Delivery
Articles/ R&D/ Views and analysis
Inhalation technology: the future of effective respiratory treatments
Linda Banks
Inhalation, inhalation technology, respiratory, respiratory conditions
0 Comment
Simon Moore discusses non-clinical development channels: technical strategies, formulations and devices.